Cement Production

With healthy demand drivers for cement - urban housing, government's infrastructure and rural development thrust, the industry is expected to close FY23 with a production of 380-390 mn ton

The two will be organising webinars, roundtables, industry meetings, and thought leadership articles towards knowledge building for the sector

After acquisition, Dalmia's capacity mix will include 52 per cent in the east, 26 per cent in the south, 16 per cent in the central region and 6 per cent in the west

Shree Cement adding 9 mtpa of capacity in the next 15 months, HM Bangur says; total cement production capacity of company to jump to 56.4 mtpa...

Operating profit margins likely to contract by 320-380 basis points to 16.3-16.8 per cent in FY23, says CareEdge Ratings, as input cost pressures remain

The company said profitability was impaired by a sharp increase in power and fuel costs, which could not be passed on to consumers

Cement major on track to reach 131.25 mtpa by Q4

Net sales up 7%; royalty agreement with Holcim terminated on Sept 16; paid Rs 264 cr as royalty and technical fees in CY21

Cost pressures a concern, though, as crude, currency volatility remain

Current consolidated capacity is about 20 mn tonnes; mix of greenfield and brownfield projects, de-bottlenecking existing operations to help add another 10 mn tonnes

Despite a high double-digit demand growth, the profitability of cement companies is set to fall by 15 per cent because price hikes lag increase in production cost, according to a report. The report by rating agency Crisil, however, said that higher demand will cushion the credit outlook for the sector. Operating profitability of cement makers will decline 15 per cent year-on-year to Rs 900-925 per tonne this fiscal, adding to the pain of a 9 per cent decline last fiscal, as an increase in realisations will not be enough to offset the increase in prices of coal, petcoke and diesel that has pushed the average cost of production higher, the agency said in a report on Monday. However, the 17 per cent demand growth in cement demand during the first quarter, albeit on the low base last fiscal, offers a silver lining, the report noted, saying though growth may taper in subsequent quarters, and print in at 8-10 per cent for the full fiscal, it will still be the highest since fiscal 2019. O

MP Birla Group firm Birla Corporation plans to increase its cement production capacity by 50 per cent to 30 million tonnes per annum by 2030, the company said in its latest annual report. The company, which has commissioned a greenfield unit at Mukutban, Maharashtra with an investment of Rs 2,744 crore, has plans to set up some new units and expand the production capacity of the existing units. "Birla Corporation Ltd is committed to increasing its annual cement production capacity to approximately 30 million tonnes (MT) by 2030. Our current production capacity stands at 20 million tonnes," it said. This ambitious expansion plan promises a buoyant outlook by ensuring improved profitability and cash flow and efficiency, said Birla Corporation. Birla Corporation and its subsidiary RCCPL Private Limited (formerly Reliance Cement Company Private Limited) currently operate 11 cement plants. Besides, it also operates a jute mill. As part of the expansion, Birla Corporation has inaugurat

Rather than simply putting up hoardings and banners or setting up stalls, companies are going for innovative ways to strike a chord with their target audience in small towns and villages

Other key players have also announced plans to significantly raise capacities

The product has the potential to reduce CO2 emissions

Bulk cement dispatch constitutes around 25 per cent of the total cement production of nearly 350 million tonnes

The company had registered standalone profits at Rs 62.02 crore during the corresponding quarter in the previous year

The work on the project will commence in November

Over the outlook, Ambuja Cements said, domestic activity in India is on an improving trend with the reduction in COVID-19 cases and supported by the increased pace of vaccinations.

The trial runs at the new plant were on since August